High-Complexity shRNA Libraries and PI3 Kinase Inhibition in Cancer: High-Fidelity Synthetic Lethality Predictions

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Deregulated signal transduction is a key hallmark of cancer, necessitating combination therapies.
• The complexity of cancer signaling pathways requires comprehensive data resources for effective treatment strategies.

Purpose of the Study:

• To develop a searchable database resource for synthetic lethality interactions involving PI3 kinase (PI3K) signaling inhibitors.
• To identify and validate novel combination therapies for cancer using a high-throughput screening approach.

Main Methods:

• Performed a saturation screen using an ultra-complex shRNA library (30 shRNAs/gene) against PI3K signaling.
• Utilized T-cell leukemia as a screening platform to identify synthetic lethal interactions.
• Validated predicted combination therapies using small molecule inhibitors and biochemical assays.

Main Results:

• Generated a high-fidelity predictive resource for combination-based cancer therapies.
• Confirmed ten predicted synthetic lethal interactions with small molecule inhibitors.
• Uncovered a synergistic mechanism between PI3K inhibitor GDC0941 (pictilisib) and tubulin inhibitor vincristine, demonstrating broad synergy across 28 cell lines and efficacy in preclinical leukemia models.

Conclusions:

• The developed database resource effectively predicts synthetic lethality and combination therapies.
• The identified synergy between PI3K and tubulin inhibitors represents a promising therapeutic strategy for multiple cancer types, including leukemia.
• This work provides a foundation for developing novel, data-driven combination treatments for cancer.